Clicky

SI-BONE, Inc.(SIBN)

Description: SI-BONE is a medical device company that pioneered the iFuse Implant System, a minimally invasive surgical system for fusion of the sacroiliac joint to treat sacroiliac joint dysfunction. The SI joint is believed to be the last major joint with a clinically proven surgical treatment. The iFuse Implant, commercially available since 2009, is believed to be the only SI joint fusion device supported by multiple prospective clinical studies showing improved pain, patient function and quality of life resulting from treatment. There are over 60 peer-reviewed publications supporting the safety, effectiveness, and biomechanical and economic benefits unique to the iFuse Implant. This body of evidence has enabled multiple government and private payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.


Keywords: Medicine Surgery Bone Implant Prosthetics Dysfunction Quality Of Life Minimally Invasive Procedure Surgical Treatment Pelvis Medical Classification Sacroiliac Joint Joint Dysfunction

Home Page: si-bone.com

SIBN Technical Analysis

471 El Camino Real
Santa Clara, CA 95050
United States
Phone: 408 207 0700


Officers

Name Title
Ms. Laura A. Francis MBA CEO & Director
Mr. Anshul Maheshwari Chief Financial Officer
Mr. Anthony J. Recupero Pres of Commercial Operations
Mr. Michael A. Pisetsky Sr. VP of Operations & Admin., Sec. and Chief Legal Officer
Mr. Jeff Bertolini Sr. VP of Operations & Information Technology
Dr. Scott A. Yerby Sr. VP of Engineering & CTO
Mr. Joseph W. Powers VP of Corp. Marketing
Ms. Aimee Einstein VP of People & Culture
Dr. Daniel Joseph Cher Sr. VP of Clinical & Regulatory Affairs
Dr. W. Carlton Reckling Chief Medical Officer & VP of Medical Affairs

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 4.2639
Price-to-Sales TTM: 4.3152
IPO Date: 2018-10-17
Fiscal Year End: December
Full Time Employees: 352
Back to stocks